Covered recipient · General Payments record
THERESA THIELE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$3,522.78
- Reported across 93 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,173.81 | 16 |
| Education | $16.90 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $557.02 | 10 |
| REVANCE THERAPEUTICS, INC. | $266.63 | 4 |
| MERZ NORTH AMERICA, INC. | $250.45 | 2 |
| Galderma Laboratories, L.P. | $116.61 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.65 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108299446 | CMS |
| ABBVIE INC. | $128.26 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108299448 | CMS |
| ABBVIE INC. | $50.67 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108299450 | CMS |
| ABBVIE INC. | $69.87 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108299452 | CMS |
| ABBVIE INC. | $96.15 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108299454 | CMS |
| ABBVIE INC. | $17.67 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108299456 | CMS |
| ABBVIE INC. | $3.85 | 04/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108299458 | CMS |
| ABBVIE INC. | $8.45 | 05/21/2024 | Education | Undisputed | 01/23/2026 | 1108299460 | CMS |
| ABBVIE INC. | $8.45 | 05/21/2024 | Education | Undisputed | 01/23/2026 | 1108299462 | CMS |
| ABBVIE INC. | $150.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108299464 | CMS |
| Galderma Laboratories, L.P. | $17.14 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145396233 | CMS |
| Galderma Laboratories, L.P. | $99.47 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145396235 | CMS |
| MERZ NORTH AMERICA, INC. | $50.63 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146394877 | CMS |
| MERZ NORTH AMERICA, INC. | $199.82 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146394879 | CMS |
| REVANCE THERAPEUTICS, INC. | $58.64 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147952148 | CMS |
| REVANCE THERAPEUTICS, INC. | $67.70 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147952150 | CMS |
| REVANCE THERAPEUTICS, INC. | $37.90 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147952152 | CMS |
| REVANCE THERAPEUTICS, INC. | $102.39 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147952154 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.